(Q41549338)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Javier Briones Meijide

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ferran Navarro

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Núria Rabella

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

David Valcarcel

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

I García-Cadenas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

N Castillo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

R Martino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

P Barba

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

A Esquirol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

G Orti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

A Garrido

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

S Saavedra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

C Moreno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

M Granell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

S Brunet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

I Ruiz

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

J Sierra

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

12 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

579-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25581404%20AND%20SRC:MED&resulttype=core&format=json

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Invasive fungal infections in hematology: new trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

How I treat EBV lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.298

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25581404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1994 Consensus Conference on Acute GVHD Grading

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25581404